TABLE 6.
Distribution of Hepatic Apparent Diffusion Coefficient Values (× 10−3 mm2/s) in 88 Patients Stratified by MR Hardware and METAVIR Fibrosis Stage
| Siemens Avanto (n=52) | GE Signa (N=36) | ||||
|---|---|---|---|---|---|
| METAVIR | No. Subjects (%) | Mean Liver ADC ± SD | No. Subjects (%) | Mean Liver ADC ± SD | P* |
| 0 | 18 (34.6%) | 1.57 ± 0.31 | 15 (41.7%) | 1.65 ± 0.10 | 0.32 |
| 1 | 9 (17.3%) | 1.31 ± 0.19 | 11 (30.6%) | 1.53 ± 0.12 | 0.006 |
| 2 | 1 (1.9%) | 1.23 | 1 (2.8%) | 1.48 | n/a |
| 3 | 3 (5.8%) | 1.39 ± 0.28 | 3 (8.3%) | 1.48 ± 0.23 | 0.70 |
| 4 | 21 (40.4%) | 1.32 ± 2.60 | 6 (16.7%) | 1.35 ± 0.16 | 0.77 |
P for Student T test comparing mean ADC of the 2 MR scanners within each METAVIR stage.
SD indicates standard deviation.